Accelerate Diagnostics In... (AXDX)
undefined
undefined%
At close: undefined
1.31
-1.50%
After-hours Dec 13, 2024, 04:00 PM EST

Accelerate Diagnostics Statistics

Share Statistics

Accelerate Diagnostics has 25.04M shares outstanding. The number of shares has increased by 64.81% in one year.

Shares Outstanding 25.04M
Shares Change (YoY) n/a
Shares Change (QoQ) 7.39%
Owned by Institutions (%) n/a
Shares Floating 15.23M
Failed to Deliver (FTD) Shares 5.30K
FTD / Avg. Volume 8.91%

Short Selling Information

The latest short interest is 473.08K, so 1.89% of the outstanding shares have been sold short.

Short Interest 473.08K
Short % of Shares Out 1.89%
Short % of Float 3.23%
Short Ratio (days to cover) 7.77

Valuation Ratios

The PE ratio is -0.79 and the forward PE ratio is -1.15.

PE Ratio -0.79
Forward PE -1.15
PS Ratio 4.06
Forward PS 1.4
PB Ratio -2.46
P/FCF Ratio -1.19
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Accelerate Diagnostics Inc. has an Enterprise Value (EV) of 75.99M.

EV / Earnings -1.23
EV / Sales 6.3
EV / EBITDA -1.53
EV / EBIT -1.41
EV / FCF -1.84

Financial Position

The company has a current ratio of 2.03, with a Debt / Equity ratio of -1.85.

Current Ratio 2.03
Quick Ratio 1.76
Debt / Equity -1.85
Total Debt / Capitalization 217.4
Cash Flow / Debt -1.09
Interest Coverage -6.98

Financial Efficiency

Return on equity (ROE) is 3.1% and return on capital (ROIC) is -283.38%.

Return on Equity (ROE) 3.1%
Return on Assets (ROA) -1.96%
Return on Capital (ROIC) -283.38%
Revenue Per Employee 89.99K
Profits Per Employee -459.84K
Employee Count 134
Asset Turnover 0.38
Inventory Turnover 2.87

Taxes

Income Tax 850.00K
Effective Tax Rate -0.01

Stock Price Statistics

The stock price has increased by -71.15% in the last 52 weeks. The beta is 0.6, so Accelerate Diagnostics 's price volatility has been higher than the market average.

Beta 0.6
52-Week Price Change -71.15%
50-Day Moving Average 1.77
200-Day Moving Average 1.37
Relative Strength Index (RSI) 30.9
Average Volume (20 Days) 59.46K

Income Statement

In the last 12 months, Accelerate Diagnostics had revenue of $12.06M and earned -$61.62M in profits. Earnings per share was $-4.94.

Revenue 12.06M
Gross Profit 2.55M
Operating Income -54.03M
Net Income -61.62M
EBITDA -49.77M
EBIT -54.03M
Earnings Per Share (EPS) -4.94
Full Income Statement

Balance Sheet

The company has $12.14M in cash and $39.22M in debt, giving a net cash position of -$27.08M.

Cash & Cash Equivalents 12.14M
Total Debt 39.22M
Net Cash -27.08M
Retained Earnings -668.86M
Total Assets 32.31M
Working Capital 9.18M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$40.20M and capital expenditures -$1.03M, giving a free cash flow of -$41.23M.

Operating Cash Flow -40.20M
Capital Expenditures -1.03M
Free Cash Flow -41.23M
FCF Per Share -3.3
Full Cash Flow Statement

Margins

Gross margin is 21.15%, with operating and profit margins of -448.03% and -510.97%.

Gross Margin 21.15%
Operating Margin -448.03%
Pretax Margin -503.92%
Profit Margin -510.97%
EBITDA Margin -412.73%
EBIT Margin -448.03%
FCF Margin -341.91%

Dividends & Yields

AXDX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -371.43%
FCF Yield -123.79%
Dividend Details

Analyst Forecast

The average price target for AXDX is $1, which is -24.8% lower than the current price. The consensus rating is "Hold".

Price Target $1
Price Target Difference -24.8%
Analyst Consensus Hold
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jul 12, 2023. It was a backward split with a ratio of 1:10.

Last Split Date Jul 12, 2023
Split Type backward
Split Ratio 1:10

Scores

Altman Z-Score -34.07
Piotroski F-Score 4